Decibel Therapeutics Performance
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Decibel Therapeutics are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Decibel Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Decibel Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 37.6 M | |
| Total Cashflows From Investing Activities | 55.1 M |
Decibel |
Decibel Therapeutics Relative Risk vs. Return Landscape
If you would invest (100.00) in Decibel Therapeutics on December 23, 2024 and sell it today you would earn a total of 100.00 from holding Decibel Therapeutics or generate -100.0% return on investment over 90 days. Decibel Therapeutics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Decibel, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Decibel Therapeutics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Decibel Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Decibel Therapeutics, and traders can use it to determine the average amount a Decibel Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| DBTX |
Based on monthly moving average Decibel Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Decibel Therapeutics by adding Decibel Therapeutics to a well-diversified portfolio.
Decibel Therapeutics Fundamentals Growth
Decibel Stock prices reflect investors' perceptions of the future prospects and financial health of Decibel Therapeutics, and Decibel Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Decibel Stock performance.
| Return On Equity | -0.77 | |||
| Return On Asset | -0.33 | |||
| Current Valuation | 62.95 M | |||
| Shares Outstanding | 25.13 M | |||
| Price To Book | 0.67 X | |||
| EBITDA | (62.49 M) | |||
| Cash And Equivalents | 125.65 M | |||
| Cash Per Share | 5.03 X | |||
| Total Debt | 14.05 M | |||
| Debt To Equity | 0.14 % | |||
| Book Value Per Share | 2.12 X | |||
| Cash Flow From Operations | (56.9 M) | |||
| Earnings Per Share | (2.56) X | |||
| Total Asset | 123.37 M | |||
| Retained Earnings | (277.52 M) | |||
Things to note about Decibel Therapeutics performance evaluation
Checking the ongoing alerts about Decibel Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Decibel Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Decibel Therapeutics is not yet fully synchronised with the market data | |
| Decibel Therapeutics has some characteristics of a very speculative penny stock | |
| Decibel Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (63.01 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Decibel Therapeutics currently holds about 125.65 M in cash with (56.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.03. | |
| Roughly 62.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Decibel Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Decibel Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Decibel Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Decibel Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Decibel Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Decibel Therapeutics' stock. These opinions can provide insight into Decibel Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Decibel Stock
If you are still planning to invest in Decibel Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Decibel Therapeutics' history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |